Skip to main content
Home / Current Clinical Pharmacology, Volume 5, Number 3
Current Clinical Pharmacology publishes frontier reviews on all the latest advances in clinical pharmacology. The journal's aim is to publish the highest quality review articles in the field. Topics covered include: pharmacokinetics; therapeutic trials; adverse drug reactions; drug interactions; drug metabolism; pharmacoepidemiology; and drug development. The journal is essential reading for all researchers in clinical pharmacology.

Current Clinical Pharmacology is now published as Current Reviews in Clinical and Experimental Pharmacology Formerly Current Clinical Pharmacology.

Publisher: Bentham Science Publishers

More about this publication?
Volume 5, Number 3, 2010

Articles

Free Content Editorial [Hot topic: Selected New Developments in Oncology (Guest Editors: Jos H. Beijnen and Jan H.M. Schellens)]
pp. 140-140(1)
Authors: H. Beijnen, Jos; H.M. Schellens, Jan

Favourites:
ADD

Personalized Medicine in Oncology: A Personal View with Myths and Facts
pp. 141-147(7)
Authors: H. Beijnen, Jos; H.M. Schellens, Jan

Favourites:
ADD

Monoclonal Antibody Therapy in Haematological Malignancies
pp. 148-159(12)
Authors: E.D. Chamuleau, Martine; A. van de Loosdrecht, Arjan; C. Huijgens, Peter

Favourites:
ADD

Monoclonal Antibodies in Solid Tumours
pp. 160-165(6)
Authors: Markman, Ben; Tabernero, Josep

Favourites:
ADD

Molecular Targeted Therapy in Prevalent Tumors: Learning from the Past and Future Perspectives
pp. 166-177(12)
Authors: Metzger-Filho, Otto; Moulin, Camilo; Awada, Ahmad

Favourites:
ADD

Vascular Disrupting Agents (VDAs) in Anticancer Therapy
pp. 178-185(8)
Authors: G.M. Daenen, Laura; M.L. Roodhart, Jeanine; Shaked, Yuval; E. Voest, Emile

Favourites:
ADD

Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents
pp. 186-191(6)
Authors: Leijen, Suzanne; H. Beijnen, Jos; H.M. Schellens, Jan

Favourites:
ADD

Inducing Synthetic Lethality using PARP Inhibitors
pp. 192-195(4)
Authors: S. Boss, David; H. Beijnen, Jos; H.M. Schellens, Jan

Favourites:
ADD

Role of Histone Deacetylases and Their Inhibitors in Cancer Biology and Treatment
pp. 196-208(13)
Authors: H. Beumer, Jan; Tawbi, Hussein

Favourites:
ADD

Pharmacogenetics of Irinotecan Disposition and Toxicity: A Review
pp. 209-217(9)
Authors: Fujita, Ken-ichi; Sparreboom, Alex

Favourites:
ADD

DNA Vaccination in Oncology: Current Status, Opportunities and Perspectives
pp. 218-225(8)
Authors: H. van den Berg, Joost; Oosterhuis, Koen; H. Beijnen, Jos; Nuijen, Bastiaan; B.A.G. Haanen, John

Favourites:
ADD

Scheduling of Taxanes: A Review
pp. 226-231(6)
Authors: J. Woodward, Emma; Twelves, Chris

Favourites:
ADD

Share Content

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content